Revium Rx (RVRC) Non-Current Assets (2024 - 2026)
Revium Rx's (RVRC) quarterly Non-Current Assets came in at $5.3 million in Q2 2026, up 0.9% quarter-over-quarter from $5.2 million in Q4 2025.
Analysis
Revium Rx (RVRC) Non-Current Assets (2024 - 2026) Analysis & Trends
Revium Rx has disclosed Non-Current Assets across 3 years of filings, most recently posting $5.3 million for Q2 2026.
- In Q2 2026, Non-Current Assets changed N/A year-over-year to $5.3 million; the TTM figure through Jun 2026 stood at $5.3 million (changed N/A YoY), while the FY2025 annual figure was $5.2 million, down 64.74% from the prior year.
- Non-Current Assets came in at $5.3 million for Q2 2026 at Revium Rx, up from $5.2 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $14.8 million in Q4 2024 to a low of $5.2 million in Q4 2025.
- Average Non-Current Assets over 3 years is $8.4 million, with a median of $5.3 million recorded in 2026.
- The largest YoY upside for Non-Current Assets was 64.74% in 2025 against a maximum downside of 64.74% in 2025.
- Over 3 years, Non-Current Assets stood at $14.8 million in 2024, then tumbled by 64.74% to $5.2 million in 2025, then climbed by 0.9% to $5.3 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $5.3 million in Q2 2026, $5.2 million in Q4 2025, and $14.8 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 60.68 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 35.42 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 14.88 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 23.28 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 5.15 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 24.78 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Revium Rx | 86.84 Mn | 85.34 Mn | - | 5.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.25 Mn |
| Dec 31, 2025 | 5.21 Mn |
| Dec 31, 2024 | 14.77 Mn |